Financials

  • Market Capitalization 52.36 M
  • Employee 17
  • Founded 2018
  • CEO N/A
  • Website www.instilbio.com
  • Headquarter New York, United States
  • FIGI BBG00ZGYN521
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.03
Rapporto prezzo/fatturato
151.55

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4243
XLO
Xilio Therapeutics, Inc. - Common Stock
9.16 USD+2.69%-0.76%-0.76%+1247.06%52.97 M USD
4244
ATYR
aTyr Pharma, Inc. - Common Stock
0.54 USD-1.82%+5.88%+12.50%-44.33%52.97 M USD
4257
HYPD
Hyperion DeFi, Inc. - Common Stock
3.28 USD-9.39%+2.50%+37.24%-49.77%50.97 M USD
4262
MCRB
Seres Therapeutics, Inc. - Common Stock
5.05 USD+2.02%+10.50%+6.54%-38.64%50.20 M USD

Notizie